B. Riley Securities Remains a Buy on OptimizeRx (OPRX)
TipRanks (Wed, 13-May 9:37 AM ET)
TipRanks (Wed, 13-May 4:15 AM ET)
TipRanks (Tue, 12-May 11:30 PM ET)
Seeking Alpha News (Tue, 12-May 8:31 PM ET)
OptimizeRx Secures New Credit Facility to Boost Flexibility
TipRanks (Tue, 12-May 5:01 PM ET)
OptimizeRx Non-GAAP EPS of $0.14 beats by $0.14, revenue of $19.84M beats by $1.49M
Seeking Alpha News (Tue, 12-May 4:17 PM ET)
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Globe Newswire (Tue, 12-May 4:01 PM ET)
Here are the major earnings after the close Tuesday
Seeking Alpha News (Tue, 12-May 10:00 AM ET)
OptimizeRx Q1 2026 Earnings Preview
Seeking Alpha News (Mon, 11-May 5:35 PM ET)
Lake Street Sticks to Its Buy Rating for OptimizeRx (OPRX)
TipRanks (Mon, 11-May 10:27 AM ET)
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
Optimizerx trades on the NASDAQ stock market under the symbol OPRX.
As of May 13, 2026, OPRX stock price declined to $4.91 with 2,151,501 million shares trading.
OPRX has a beta of 2.69, meaning it tends to be more sensitive to market movements. OPRX has a correlation of 0.25 to the broad based SPY ETF.
OPRX has a market cap of $90.88 million. This is considered a Micro Cap stock.
Last quarter Optimizerx reported $20 million in Revenue and $.14 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.16.
In the last 3 years, OPRX traded as high as $22.25 and as low as $3.78.
The top ETF exchange traded funds that OPRX belongs to (by Net Assets): VTI, IWM, VXF, IWO, DFSV.
OPRX has underperformed the market in the last year with a price return of -46.6% while the SPY ETF gained +28.6%. OPRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.1% and -23.2%, respectively, while the SPY returned +9.2% and +4.3%, respectively.
OPRX support price is $6.05 and resistance is $6.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPRX shares will trade within this expected range on the day.